Rayan Kabirian
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Efficacy and safety of immune checkpoint inhibitor rechallenge in cervical and endometrial cancer: a multi-center retrospective study (RICE study).
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 23, 2026
Maternal and Neonatal Complications Associated with Breast Cancer Systemic Treatments-A VigiBase Disproportionality Analysis Study.
Journal: Clinical pharmacology and therapeutics
Published: March 22, 2026
Therapeutic advances and molecular insights in low-grade serous ovarian carcinoma.
Journal: Bulletin du cancer
Published: October 01, 2025
The transversal specialized formation in oncology for medical gynecology residents: A five-year review
Journal: Bulletin du cancer
Published: April 02, 2025
BCR::ABL1 Tyrosine Kinase Inhibitors During Pregnancy, a Disproportionality Analysis of Vigibase.
Journal: Clinical pharmacology and therapeutics
Published: December 04, 2024
TEDOVA: vaccine OSE2101 +/- pembrolizumab as maintenance in platinum-sensitive recurrent ovarian cancer.
Journal: Future oncology (London, England)
Published: August 19, 2024
Immune Checkpoint Inhibitor Use During Pregnancy and Outcomes in Pregnant Individuals and Newborns.
Journal: JAMA network open
Published: April 17, 2024
Chemotherapy-Related Amenorrhea and Quality of Life Among Premenopausal Women With Breast Cancer.
Journal: JAMA network open
Published: November 16, 2023
New drug approval: Sacituzumab govitecan in third line in advanced or metastatic triple-negative breast cancer
Journal: Bulletin du cancer
Published: December 05, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026